🔎 Trials Near Me

Home › Kanser sa Suso › Louisiana › New Orleans

Pag-aaral pangklinika para sa Kanser sa Suso sa New Orleans, LA

Isang pag-aaral para sa Kanser sa Suso ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa New Orleans. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • University Medical Center New Orleans, New Orleans
  • Touro Infirmary, New Orleans
  • West Jefferson Medical Center, Marrero · 4 mi ang layo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Nagre-recruitPhase 3
  • Ochsner Clinic Foundation ( Site 0021), New Orleans
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06966700

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Nagre-recruitPhase 3
  • University Medical Center-New Orleans, New Orleans
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06492616

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

Nagre-recruitPhase 1
  • Ochsner Medical Center (OMC), New Orleans
Edad 18 hanggang 55 · Kababaihan · Na-update Set 9, 2026 · NCT07310420

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Nagre-recruitPhase 3
  • Care Access-Marrero, Marrero · 4 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06072612

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Nagre-recruitPhase 3
  • Louisiana State University Health Science Center, New Orleans
  • University Medical Center New Orleans, New Orleans
  • Touro Infirmary, New Orleans
  • at 1 pa
Edad 18 hanggang 60 · Kababaihan · Na-update Set 2, 2026 · NCT05879926

E-Mindfulness Approaches for Living After Breast Cancer

Nagre-recruitPhase 3
  • University Medical Center New Orleans, New Orleans
Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT06748222

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2
  • Louisiana State University Health Sciences Center, New Orleans
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT05768139

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Nagre-recruitPhase 3
  • Louisiana State University Health Science Center, New Orleans
  • University Medical Center New Orleans, New Orleans
  • Ochsner Medical Center Jefferson, New Orleans
Edad 50 hanggang 70 · Lahat ng kasarian · Na-update Abr 23, 2026 · NCT04852887

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral
  • Massive Bio SYNERGY-AI site, New Orleans
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

CtDNA Based MRD Testing for NAC Monitoring in TNBC

Nagre-recruitObservasyonal na pag-aaral
  • Louisiana State University, New Orleans
Edad 18 pataas · Kababaihan · Na-update Ene 7, 2025 · NCT06230185

Pag-aaral para sa Kanser sa Suso sa ibang lungsod

Iba pang pag-aaral sa New Orleans

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.